These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6297069)

  • 1. [Significance of the presence of Australia antigen in liver diseases seen in a department of internal medicine in Abidjan].
    Soubeyrand J; Ticolat R; Leleu JP; Condat JM; Niamkey E; Diallo D; Manlan KL; Ouattara D; Beda BY
    Sem Hop; 1982 Dec; 58(46):2702-8. PubMed ID: 6297069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Etiological factors of hepatocellular carcinoma in Abidjan (Ivory Coast) (author's transl)].
    Le Bras M; Ticolat R; Clerc M; Loubière R; Beda B; Bertrand E
    Gastroenterol Clin Biol; 1978; 2(8-9):679-88. PubMed ID: 213339
    [No Abstract]   [Full Text] [Related]  

  • 3. OMGE--Study on prevalence of hepatitis B surface antigen in different liver diseases.
    Wewalka F; Hadziyannis S; Pesendorfer FX; Dragosics B; Base W
    Scand J Gastroenterol Suppl; 1979; 56():55-68. PubMed ID: 94455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Current status of the theories of the chronicity of liver diseases].
    Damianov B
    Vutr Boles; 1981; 20(2):25-32. PubMed ID: 7020250
    [No Abstract]   [Full Text] [Related]  

  • 5. alpha-1-Foeto protein (AFP) and hepatitis B surface antigen (HBsAg) in various hepatic disorders.
    Gupta SC; Satsangi JK; Mehrotra TN; Sinha SN
    J Assoc Physicians India; 1979 Jan; 27(1):1-6. PubMed ID: 92470
    [No Abstract]   [Full Text] [Related]  

  • 6. [HBS antigen and liver diseases].
    Blüger A; Kartaschowa O; Zalcmane V; Saldava L
    Dtsch Z Verdau Stoffwechselkr; 1983; 43(2):56-64. PubMed ID: 6307637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HBV and HCV prevalence and viraemia in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study.
    Rouet F; Chaix ML; Inwoley A; Msellati P; Viho I; Combe P; Leroy V; Dabis F; Rouzioux C;
    J Med Virol; 2004 Sep; 74(1):34-40. PubMed ID: 15258966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of surface antigens (HBsAg), surface antibody (HBsAb) and anticore antibody (HBcAb) in hospital personnel and patients with and without hepatic pathology].
    Ardito D; Bianco T; Demundo T; Loiodice L
    Minerva Med; 1980 Oct; 71(39):2815-20. PubMed ID: 7432690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Materno-fetal transmission of hepatitis B virus in Ivory Coast. Plea for mass vaccination].
    Lohouès-Kouacou MJ; Touré M; Hillah J; Camara BM; N'Dri N; Kouamé KJ; Attia Y
    Sante; 1998; 8(6):401-4. PubMed ID: 10064911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of antibody to hepatitis-B virus core antigen (anti-HBc) in chronic diffuse liver disease.
    Dávid K; Halmy L
    Acta Med Acad Sci Hung; 1982; 39(3-4):161-8. PubMed ID: 7185241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antigen e and anti-e in primary liver cancer, cirrhosis, and viral hepatitis in Senegal].
    Sankale M; Sow AM; Thermos M
    Afr J Med Med Sci; 1977 Sep; 6(3):157-8. PubMed ID: 97943
    [No Abstract]   [Full Text] [Related]  

  • 12. [Australia antigen in various liver diseases (except acute hepatitis). 3].
    Migneco G; Mansueto S; Tripi S
    G Mal Infett Parassit; 1971 Dec; 23(12):1125-6. PubMed ID: 5151318
    [No Abstract]   [Full Text] [Related]  

  • 13. [Geographical differences in the incidence of Australia antigen in chronic liver diseases].
    Del Vecchio Blanco C; Rinaldi M; Saffiotti O; Caporaso N; Coltorti M
    Quad Sclavo Diagn; 1975 Jun; 11(2):500-7. PubMed ID: 1223953
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-S deletion and complex mutations of hepatitis B virus related to advanced liver disease in HBeAg-negative patients.
    Chen CH; Hung CH; Lee CM; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Gastroenterology; 2007 Nov; 133(5):1466-74. PubMed ID: 17915220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis B vaccines. An evaluation of human plasma extracted vaccines].
    Prince AM; Vnek J
    Fortschr Med; 1982 Oct; 100(40):1839-43. PubMed ID: 6293948
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of serum hepatitis virus in chronic liver disease.
    Prince AM
    Gastroenterology; 1971 May; 60(5):913-21. PubMed ID: 4931955
    [No Abstract]   [Full Text] [Related]  

  • 17. Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis.
    Chung HT; Lai CL; Lok AS
    Hepatology; 1995 Jul; 22(1):25-9. PubMed ID: 7601418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue markers of hepatitis B virus infection in hepatocellular carcinoma and cirrhosis.
    Craxi A; Pasqua P; Giannuoli G; Di Stefano R; Simonetti RG; Pagliaro L
    Hepatogastroenterology; 1984 Apr; 31(2):55-9. PubMed ID: 6327478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatitis B--a viral oncogene?].
    Weis NM; Krogsgaard K
    Ugeskr Laeger; 2002 Dec; 164(50):5940-4. PubMed ID: 12553116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of the Australia antigen and of the corresponding antibody in pathology and in hospital personnel].
    Ménaché D; Boyer C; Schlegel N
    Arch Fr Mal App Dig; 1971 Dec; 60(12):649-64. PubMed ID: 5158155
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.